维罗非尼 T8654
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 1029872-54-5 | ¥970.00 | 询底价 |
1 mL | 1029872-54-5 | ¥474.00 | 询底价 |
10 mg | 1029872-54-5 | ¥430.00 | 询底价 |
5 mg | 1029872-54-5 | ¥294.00 | 询底价 |
25 mg | 1029872-54-5 | ¥690.00 | 询底价 |
100 mg | 1029872-54-5 | ¥1,491.00 | 询底价 |
500 mg | 1029872-54-5 | ¥3,868.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Plx-4032
描述: Plx-4032 (Vemurafenib) 是一种小分子 B-Raf 抑制剂,可用于治疗恶性黑色素瘤。
体内活性: PLX-4032 and its related analogs are highly potent inhibitors of B-Raf activity, with 3-fold selectivity for the V600E mutation over the wild-type kinase.?In preclinical models, PLX-4032 and its analogs inhibited the growth of BRAFV600E-positive melanoma cell lines both in vitro and in vivo[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 30 mg/mL (61.23 mM)
关键字: Plx-4032 | Plx 4032 | Plx4032 | 918504-65-1 | 18504-65-1
相关产品: RMC-0331 | 6H05 | Raf inhibitor 3 | K-Ras(G12C) inhibitor 12 | PROTAC B-Raf degrader 1 | Agerafenib | OSI-930 | TBAP-001 | ARS-853 | K-Ras-IN-1
相关库: Drug Repurposing Compound Library | FDA-Approved Kinase Inhibitor Library | Anti-Cancer Drug Library | Human Metabolite Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library | Reprogramming Compound Library | Bioactive Compound Library
维罗非尼 T8654信息由TargetMol中国为您提供,如您想了解更多关于维罗非尼 T8654报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途